Abcely is a biotech firm that is working on a novel anti-cancer medication.
Abcely has raised $2.6M in total funding. The most recent round was Seed. The last funding was announced in September 2023.
Abcely's investors include GO CAPITAL, Angels Santé, Institut de Cancérologie de l'Ouest (ICO).
Abcely is headquartered in Nantes, France.
Abcely is a biotech firm that is working on a novel anti-cancer medication.
Abcely is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Abcely — Funding & Investors." VCBacked, September 21, 2023, https://www.vcbacked.co/company/abcely. Accessed September 14, 2026.
VCBacked. (2023). Abcely — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/abcely
{{cite web |title=Abcely — Funding & Investors |url=https://www.vcbacked.co/company/abcely |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated